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Brief Report
 
JIL-1, a Chromosomal Kinase Implicated in Regulation of Chromatin 
Structure, Associates with the Male Specific Lethal (MSL) Dosage 
Compensation Complex
 
Ye Jin, Yanming Wang, Jørgen Johansen, and Kristen M. Johansen
 
Department of Zoology and Genetics, Iowa State University, Ames, Iowa 50011
 
Abstract. 
 
JIL-1 is a novel chromosomal kinase that is 
upregulated almost twofold on the male X chromo-
 
some in 
 
Drosophila
 
. Here we demonstrate that JIL-1 
colocalizes and physically interacts with male specific 
lethal (MSL) dosage compensation complex proteins. 
Furthermore, ectopic expression of the MSL complex 
directed by MSL2 in females causes a concomitant up-
regulation of JIL-1 to the female X that is abolished in 
 
msl
 
 mutants unable to assemble the complex. Thus, 
these results strongly indicate JIL-1 associates with the 
MSL complex and further suggests JIL-1 functions in 
signal transduction pathways regulating chromatin 
structure.
Key words: protein
 
 
 
kinase • dosage compensation • 
 
Drosophila • 
 
chromatin • MSL complex
 
Introduction
 
DNA tightly packed together with histones and other pro-
teins into nucleosomes is not easily accessible to the en-
zymes that use it as a template for transcription or replica-
tion. Consequently, remodeling of chromatin structure at
promoter regions may play an essential role in regulation
of gene expression (Wolffe and Hayes, 1999). Structural
changes in chromatin may also form the basis for dosage
compensation mechanisms that have evolved to equalize
levels of X-linked gene products between males and fe-
males. In humans, one of the two X chromosomes in fe-
males is inactivated by condensation of the chromosome
into a Barr body and in 
 
C
 
.
 
 elegans
 
, association of con-
densin-like molecules with the two female X chromo-
somes reduces transcription levels from each by about half
(Lucchesi, 1998). However, in contrast to these mecha-
nisms, both female X chromosomes in 
 
Drosophila
 
 are ac-
tively expressed. Consequently, in order to achieve equal
levels of expression of genes on the X chromosome, a two-
fold hyper-transcription of the male’s single X chromo-
some occurs relative to the female’s two X chromosomes
and the autosomes (Baker et al., 1994; Kelley and Kuroda,
1995; Lucchesi, 1998). This increased transcriptional activ-
ity correlates with a more diffuse chromosome structure,
such that despite the fact that it contains half the DNA
content, the male X chromosome appears to be the same
width as the paired female X chromosomes (Gorman and
Baker, 1994).
In an effort to determine the molecular basis for dosage
compensation in 
 
Drosophila
 
, a number of genetic screens
were performed that have identified several genes neces-
sary for achieving equal levels of most X-linked transcrip-
tion (Fukunaga et al., 1975; Belote and Lucchesi, 1980).
The products of these genes assemble into a complex
termed MSL (male specific lethal)
 
1
 
 that is thought to be
responsible for targeting a histone acetyltransferase that
acetylates histone H4 (H4Ac16) to the upregulated male
X chromosome, which in turn leads to altered chromatin
structure (Smith et al., 2000). The MSL holocomplex is
known to include MSL1, a novel acidic protein (Palmer et
al., 1993); MSL2, a RING finger protein (Bashaw and
Baker, 1995; Kelley et al., 1995; Zhou et al., 1995); MSL3,
a chromodomain protein (Gorman et al., 1995); MLE, an
RNA helicase (Kuroda et al., 1991); MOF, a histone
acetyltransferase (Hilfiker et al., 1997); and two nontrans-
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lated RNAs, roX1 and roX2 (Meller et al., 1997; Franke
and Baker, 1999). The MSL complex preferentially associ-
ates at hundreds of sites on the male X but fails to assem-
ble in females due to a 
 
Sex lethal
 
–regulated block in trans-
lation of the MSL2 subunit (reviewed in Bashaw and
Baker, 1996). The MSL complex colocalizes with the
H4Ac16 pattern on the male X chromosome, and absence
of any of the MSL complex subunits prevents both MSL
complex assembly as well as the enhanced H4Ac16 modi-
fication on the male X chromosome (Turner et al., 1992;
Bone et al., 1994). Furthermore, studies have shown that
ectopic expression of MSL2 in females results in formation
and targeting of the MSL complex to both female X chro-
mosomes with a concomitant upregulation of H4Ac16 lev-
els (Kelley et al., 1995; Bashaw and Baker, 1995).
Thus, in order to understand the mechanisms of dosage
compensation occurring in 
 
Drosophila
 
 it is necessary to
identify all the components of the MSL complex and to
determine how they may interact to mediate upregulation
of transcription on the male X. Recently, we have charac-
terized a novel tandem kinase, JIL-1, which is enriched al-
most twofold on the male larval polytene X-chromosome
(Jin et al., 1999). In this study, we demonstrate (a) that
JIL-1 colocalizes with the MSL complex proteins on the
male X, (b) that JIL-1 can molecularly interact with MSL
complex proteins, (c) that ectopic expression of MSL2 in
females causes a concomitant upregulation of JIL-1 to the
female X, and (d) that this upregulation is abolished in 
 
msl
 
mutants that are unable to assemble the complex. Thus,
these results strongly indicate that JIL-1 can associate with
the MSL dosage compensation complex. The ability of
JIL-1 to phosphorylate histone H3 in vitro
 
 
 
(Jin et al., 1999)
further suggests a model where JIL-1’s role in the MSL
complex is to assist in regulating transcription possibly
through modification of chromatin.
 
Materials and Methods
 
Drosophila Stocks
 
Fly stocks were maintained according to standard protocols (Roberts,
1986). Oregon-R was used for wild-type preparations. The 
 
w; msl3 
 
[
 
w
 
1
 
H83M2-6I]/TM6, Tb e and 
 
w; msl1
 
L60
 
/CyO
 
;
 
 
 
[
 
w
 
1
 
 H83M2-6I] stocks
(Kelley et al., 1995) were the generous gift of Drs. M. Kuroda and R.
Kelley (Baylor College of Medicine, Houston, TX).
 
Immunohistochemistry
 
Anti–JIL-1 IgY antibodies were purified from eggs of chickens (Aves
Labs) that had been injected with pGEXFI, a GST (glutathione-
 
S
 
-trans-
ferase)–JIL-1 fusion protein containing residues 886–1,013 (Jin et al.,
1999). A JIL-1–specific monoclonal antibody, 5C9, was made to pGEXFI
using standard procedures (Harlow and Lane, 1988). Affinity-purified
anti-MSL1 (rabbit), -MSL2 (rabbit), and -MSL3 (goat) antibodies were
the generous gift of Drs. M. Kuroda and R. Kelley. Polytene chromosome
squash preparations from late third instar larvae were double immu-
nostained using FITC- and TRITC-conjugated species-specific secondary
antibodies as previously described by Jin et al. (1999).
Confocal microscopy was performed with a Leica confocal TCS NT mi-
croscope system equipped with separate Argon-UV, Argon, and Krypton
lasers and the appropriate filter sets for Hoechst, FITC, and TRITC imag-
ing. A separate series of confocal images for each fluorophor of double la-
beled preparations was obtained simultaneously with z intervals of typi-
cally 0.5 
 
m
 
m. An average projection image for each of the image stacks
was obtained using the NIH-image software. These were subsequently im-
ported into Photoshop where they were pseudocolored, image processed,
and merged.
 
JIL-1 Fusion Protein Constructs
 
An inducible full-length JIL-1 fusion protein with COOH-terminal V5
and His6 tags for expression in S2 cells was constructed by site-directed
mutagenesis using the Transformer kit (CLONTECH Laboratories, Inc.)
and inserted into the pMT/V5-His6 B vector (Invitrogen). The resulting
construct was verified by sequencing and stably transformed into S2 cells
using standard procedures for transfection and S2 cell line culture (Invi-
trogen).
A nearly full-length GST–JIL-1 fusion protein (residues 34–1,207) as
well as various truncated GST–JIL-1 fusion proteins were constructed by
PCR and inserted into the pGEX4T-2 (Amersham Pharmacia) vector for
expression in 
 
E
 
. 
 
coli
 
. The following four truncated GST–JIL-1 fusion pro-
teins were made: NTD (residues 1–211), KDI (residues 251–554), KDII
(residues 615–917), and CTD (residues 927–1,207). The GST fusion pro-
tein constructs were verified by sequencing and fusion proteins purified
using glutathione agarose beads (Sigma-Aldrich) following standard pro-
tocols (Amersham Pharmacia).
 
Coimmunoprecipitation and In Vitro Protein 
Interaction Assays
 
For immunoprecipitation (ip) experiments with V5-tagged JIL-1, 3 
 
m
 
g
anti-V5 monoclonal antibody (Invitrogen) was coupled with 5 
 
m
 
l protein
G–Sepharose beads (Amersham Pharmacia) for 2 h at 4
 
8
 
C on a rotating
wheel in 50 
 
m
 
l ip buffer (20 mM Tris-HCl, 150 mM NaCl, 10 mM EDTA, 1
mM EGTA, 0.2% Triton X-100, 0.2% NP-40, 2 mM Na
 
3
 
VO
 
4
 
, 1 mM PMSF
and 1.5 
 
m
 
g/ml aprotinin, pH 8.0) and then incubated overnight at 4
 
8
 
C with
S2 cell lysate (10
 
6
 
 cells/200 
 
m
 
l ip buffer) from cells stably expressing a V5–
JIL-1 fusion protein or from control cells not expressing V5–JIL-1. For
coimmunoprecipitation experiments with MSL proteins, 1 
 
m
 
g anti-MSL1,
1 
 
m
 
g anti-MSL2, 2 
 
m
 
g anti-MSL3, or identical amounts of the appropriate
control antibodies (rabbit preimmune sera or normal goat sera from
GIBCO BRL) were coupled with 5 
 
m
 
l protein G–Sepharose beads (Amer-
sham Pharmacia) for 2 h at 4
 
8
 
C on a rotating wheel in 50 
 
m
 
l ip buffer. S2
cell lysate from V5–JIL-1–expressing cells was prepared in ip buffer (10
 
6
 
cells/200 
 
m
 
l ip buffer) and precleared with 5 
 
m
 
l normal sera and 20 
 
m
 
l pro-
tein G beads for 2 h at 4
 
8
 
C. The precleared lysate and protein G beads
preloaded with the appropriate antibody were combined and incubated
overnight at 4
 
8
 
C with continuous mixing. Beads were then washed four
times for 10 min each with 1 ml of ip buffer. The resulting immunocom-
plexes were analyzed by SDS-PAGE and Western blotting according to
standard techniques as described in Jin et al. (1999). In some experiments,
endogenous JIL-1 and MSL proteins were immunoprecipitated from ly-
sate of untransfected S2 cells using the same procedure. For in vitro pro-
tein–protein interaction assays, 
 
z
 
0.5 
 
m
 
g of GST or the appropriate GST
fusion protein were coupled with glutathione agarose beads and incubated
with 300 
 
m
 
l of S2 cell lysate (from 
 
z
 
10
 
6
 
 cells) at 4
 
8
 
C for 6 h on a rotating
wheel. The beads were washed 4 times for 10 min each with 1 ml ip buffer,
and proteins retained on the glutathione agarose beads were analyzed by
SDS-PAGE and Western blotting with signals detected by ECL chemilu-
minescence (Amersham Pharmacia).
 
Results
 
MSL Complex Proteins on the Male X Chromosome 
Colocalize with JIL-1
 
JIL-1 kinase localizes to interband regions on both male
and female polytene chromosomes but is upregulated al-
most twofold on the male X chromosome (Jin et al., 1999)
in a pattern reminiscent of antibody labeling of proteins in
the MSL complex (Kuroda et al., 1991; Gorman et al.,
1995; Zhou et al., 1995). Thus, in order to determine the
relationship of JIL-1 localization with respect to the MSL
dosage compensation complex proteins, chromosomal
squashes prepared from larval salivary glands were double
labeled with JIL-1 antisera and with either MSL1, MSL2,
or MSL3 antibody. Fig. 1 shows an example of such a dou-
ble labeling for JIL-1 and MSL1-specific antibodies. JIL-1
localization is shown in green, MSL1 protein localization
 Jin et al. 
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in red, and colocalization is indicated by yellow regions in
the composite image. The predominantly yellow labeling
in the composite image indicates that JIL-1 colocalizes
with MSL1 along the entire length of the male X chromo-
some except at the tip (Fig. 1 A, arrow). At some band lo-
cations in the composite image the color is more green or
orange than pure yellow due to slight differences in the
relative staining intensity of the two antibodies that can
vary from preparation to preparation. However, in all
cases examined, the banding patterns themselves over-
lapped (except at the tip; Fig. 1, B and C). Identical results
were obtained in double labelings with JIL-1 and MSL2
and MSL3 antibodies (data not shown). In contrast with
JIL-1 (Jin et al., 1999) neither MSL1, MSL2, nor MSL3 are
found at significant levels on the autosomes (Bashaw and
Baker, 1996).
 
JIL-1 Upregulation on X Chromosomes Depends on the 
Presence of the MSL Complex
 
The observed colocalization of JIL-1 with the MSL pro-
teins led us to ask whether JIL-1 would also be inappropri-
ately upregulated on the female X chromosomes in the
presence of ectopic MSL2. This has been demonstrated
to be the case for other proteins in the MSL complex
(Bashaw and Baker, 1995; Kelley et al., 1995). Chromo-
somal squashes prepared from salivary glands of third
instar female larvae that ectopically express MSL2 in a
heterozygous 
 
msl1
 
 or 
 
msl3
 
 background and thus have as-
sembled MSL complexes on their paired X chromosomes
were immunostained with JIL-1 antibody. When the MSL
complex is targeted to the female X chromosomes, it is ac-
companied by a concomitant increase of JIL-1 localization
(Fig. 2, A and C). That this increase is dependent on the
presence of the MSL complex is supported by JIL-1 im-
munostainings of female polytene chromosome squashes
ectopically expressing MSL2 in an 
 
msl1
 
/
 
msl1
 
 or 
 
msl3
 
/
 
msl3
 
homozygous background incapable of MSL complex as-
sembly due to absence of the MSL1 or MSL3 subunit, re-
spectively. In these females JIL-1 is no longer upregulated
on the paired X chromosomes (Fig. 2, B and D) but now is
found distributed on both X chromosomes and throughout
all of the autosomes in a pattern consistent with its normal
wild-type localization. These results suggest that the up-
regulation of JIL-1 on the male X chromosome is directly
correlated with the presence of the MSL complex. There
are two possible scenarios that can account for these ob-
servations: either JIL-1 is an integral component of the
MSL complex itself or the activity of the MSL complex di-
rects the upregulation of JIL-1 to specific sites on the X
chromosome.
 
JIL-1 Molecularly Interacts with the MSL Complex
 
To address whether JIL-1 may associate with the MSL
dosage compensation complex, we performed coimmuno-
precipitation experiments designed to test for molecular
interactions. We used protein extracts from the 
 
Dro-
sophila 
 
S2 cell line that expresses both the MSL complex
(Copps et al., 1998) as well as JIL-1 (Jin et al., 1999). To
facilitate the cross-immunoprecipitation experiments, we
introduced a V5-epitope–tagged full-length JIL-1 construct
into stably transfected S2 cells. The V5-tagged JIL-1 fu-
sion protein can be detected in Western blot analysis (Fig.
3 A, S2 lysate) and retains its kinase activity (data not
shown). For immunoprecipitation experiments, proteins
were extracted from the transfected S2 cells, fractionated
on SDS-PAGE after ip, Western blotted, and probed with
the appropriate antibodies. Fig. 3 A shows ip experiments
using either anti-MSL1 (top panel), anti-MSL2 (middle
panel), or anti-MSL3 (bottom panel). All three antibodies
were able to coimmunoprecipitate V5-tagged JIL-1 as
shown on Western blots probed with anti-V5 antibody.
The V5-tagged JIL-1 can be detected in the total S2 lysate,
but is not immunoprecipitated by any of the normal sera
control ips. Fig. 3 B shows the converse experiment: anti-
V5 monoclonal antibody was able to coimmunoprecipitate
MSL1 (top panel) and MSL2 (bottom panel) as well as
Figure 1. Colocalization of JIL-1 with MSL1 protein on the male X chromosome. Double labeling of male polytene chromosomes with
antibodies against JIL-1 (B) and MSL1 (C) reveals identical banded staining patterns on the X chromosome. The composite image (A)
shows the extensive overlap between JIL-1 (green) and MSL1 (red) labeling as indicated by the predominantly yellow banding. The
only exception to the colocalization between JIL-1 and MSL1 is found at the tip of the X (arrow) that specifically stains for JIL-1 only.
Unlike JIL-1, MSL1 was not detectable on the autosomes (B and C).
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MSL3 (data not shown) from S2 cells that were stably ex-
pressing V5-tagged JIL-1, but not from control untrans-
fected S2 cells that do not express the V5–JIL-1 fusion
protein. Fig. 3 C shows that endogenous JIL-1 can be
immunoprecipitated by MSL1 antibody and, conversely,
MSL1 can be immunoprecipitated by JIL-1 antibody from
untransfected S2 cell lysate. These results demonstrate a
molecular interaction of JIL-1 with the MSL complex.
However, since immunoprecipitation of any one of the MSL
complex proteins will co-ip the other proteins (Copps et
al., 1998), it does not indicate whether any of these pro-
teins interact directly with JIL-1.
To further characterize which region(s) of the JIL-1 ki-
nase is likely to interact with other components of the
MSL dosage compensation complex, we generated GST–
JIL-1 fusion proteins covering different domains of JIL-1
including a nearly full-length JIL-1 construct (GST–JIL-
1), the NH
 
2
 
-terminal domain (GST-NTD), the first kinase
domain (GST-KDI), the second kinase domain (GST-
KDII), and the COOH-terminal domain (GST-CTD)
(Fig. 4 A). These GST–JIL-1 fusion proteins or a GST-
only control were coupled with glutathione agarose beads,
incubated with S2 lysate, washed, fractionated by SDS-
PAGE, and analyzed by Western blot analysis using anti-
bodies specific for MSL1 or MSL3 (Fig. 4 B). Whereas the
 
GST-only control showed no pull-down activity for either
MSL protein, GST–JIL-1 was able to pull down both
MSL1 and MSL3. Furthermore, we found that this pull-
down activity was specific to the kinase domains of JIL-1:
both GST-KDI and GST-KDII were able to pull down
both MSL1 and MSL3, but neither GST-NTD nor GST-
CTD showed such activity. These results suggest that the
direct molecular interaction of JIL-1 with the MSL com-
plex is mediated by the kinase domains and not the NH
 
2
 
-
or COOH-terminal sequences.
 
Discussion
 
In this study, we present evidence that JIL-1 can associate
with the MSL dosage compensation complex by showing
that JIL-1 colocalizes with MSL proteins on the polytene
chromosomes and that JIL-1 physically interacts with the
MSL complex in cross-immune precipitation and pull-
down assays. Furthermore, ectopic expression of MSL2 in
females, known to inappropriately recruit the MSL com-
plex to the female X, causes a concomitant recruitment of
JIL-1 to the female X. This upregulation is abolished in 
 
msl
 
mutants that are unable to assemble the complex strongly
indicating that the upregulation of JIL-1 on the male X is
dependent on the presence of a functional MSL complex.
Figure 2. JIL-1 is upregu-
lated on female X chromo-
somes by the presence of ec-
topically expressed MSL
complex. Polytene chromo-
somes labeled with JIL-1 an-
tibody from female larvae ex-
pressing the MSL complex on
the X chromosomes (X) due
to induced ([H83M2-6I]) ec-
topic MSL2 protein expres-
sion. In msl1 (A) and msl3
(C) heterozygote back-
grounds the MSL complex is
inappropriately assembled on
the female X (Kelley et al.,
1995) with a concomitant
nearly twofold ectopic upreg-
ulation of JIL-1 as compared
with the female autosomes.
In contrast, in msl1/msl1 (B)
and msl3/msl3 (D) homozy-
gous backgrounds that are in-
capable of MSL complex as-
sembly (Kelley et al., 1995)
due to the absence of the
MSL1 and MSL3 proteins,
respectively, JIL-1 is equally
distributed on both X chro-
mosomes and autosomes in a
pattern consistent with its
wild-type distribution in fe-
males.
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The MSL complex is believed to promote dosage com-
pensation in males by targeting MOF, the histone acety-
lase responsible for the increased H4Ac16 modification
found on the male X chromosome (Smith et al., 2000).
This modification is thought to lead to a more diffuse
chromatin structure and enhanced accessibility of the
DNA for transcription. However, it is becoming increas-
ingly evident that in addition to acetylation, phosphoryla-
tion may also play a key role not only at the level of mod-
ulation of transcription factor activity, but also more
generally at the level of chromatin structure. For example,
histone H3 phosphorylation has been found to occur in a
small subset of nucleosomes in mitogenically stimulated
cells (Barratt et al., 1994; Sassone-Corsi et al., 1999). This
phosphorylation appears to be regulated by mitogen-acti-
vated signal transduction cascades indicating a direct link
between signal transduction pathways and chromatin
structure. JIL-1 has been shown to phosphorylate histone
H3 in vitro (Jin et al., 1999) suggesting that the MSL com-
plex may affect chromatin structure not only by histone
acetylation, but also by histone phosphorylation. How-
ever, the finding that JIL-1 interacts with the MSL com-
plex through its kinase domains also raises the possibility
that one or more of the proteins in the MSL complex itself
could be a substrate for JIL-1. Regardless of whether the
substrate(s) for JIL-1 is histones or components of the
MSL complex or both it is likely that the JIL-1 kinase
serves as a regulator of MSL complex function through
site-specific phosphorylation.
The finding that JIL-1 associates with the MSL complex
is based on physical interaction assays such as coimmuno-
precipitation and GST pull-down experiments. These ap-
proaches require a fairly stable interaction between JIL-1
and the MSL complex making it unlikely that this associa-
tion depends on the presence of the roX RNAs. This is in
contrast to the MLE product that is not found as part of
the MSL complex during chromatographic separation
(Copps et al., 1998), a finding consistent with it being the
Figure 3. JIL-1 physically in-
teracts with the MSL com-
plex. (A) Immunoprecipita-
tion of lysates from S2 cells
stably expressing a V5-tagged
JIL-1 fusion protein was per-
formed using either anti-
MSL1 (top panel), -MSL2
(middle panel), or -MSL3
(bottom panel) antibodies or
the appropriate control se-
rum antibody and analyzed
by SDS-PAGE and Western
blotting using anti-V5 anti-
body for detection of the V5-
tagged JIL-1 fusion protein.
V5-tagged JIL-1 is detected
in the S2 cell lysate (lane 1)
as well as in the anti-MSL1, -2,
and -3 immunoprecipitated
samples (lane 3), but is not
detected in the control sera-
immunoprecipitated samples
(lane 2). (B) Anti-V5 mono-
clonal antibody was used to
immunoprecipitate protein
from S2 cell lysate from
transfected cells expressing a
V5-tagged JIL-1 fusion pro-
tein or from control, non-
transfected S2 cells. The im-
munoprecipitated proteins
were fractionated by SDS-
PAGE, Western blotted, and
probed with anti-MSL1 (top
panel) or anti-MSL2 (bot-
tom panel) antibodies. Both
MSL1 and MSL2 were detected in the S2 cell lysate (lane 1) as
well as coimmunoprecipitated with the V5-tagged JIL-1 protein
(lane 3) from the V5–JIL-1–transfected cells, but could not be de-
tected in the untransfected control S2 cell ip samples (lane 2). (C)
Lane 1 shows endogenous JIL-1 immunoprecipitated by MSL1
antibody from lysate of untransfected S2 cells. Lane 2 shows
MSL1 immunoprecipitated from S2 cells by the JIL-1 mono-
clonal antibody, 5C9. The relative migration of molecular mark-
ers is indicated to the left in kD.
Figure 4. JIL-1 interactions with the MSL complex are mediated
by the kinase domains. (A) Diagram of the 1,207-residue JIL-1
double kinase and the five GST fusion constructs used for pull-
down assays. A nearly full-length (GST–JIL-1) and four trun-
cated (GST-NTD, GST-KDI, GST-KDII, and GST-CTD) GST–
JIL-1 fusion proteins were generated. The JIL-1 amino acid
residues included in each construct are indicated at the right. (B)
S2 cell lysate incubated with each of the JIL-1 GST fusion con-
structs diagrammed in (A) or a GST-only control was pelleted
with glutathione-agarose beads and the interacting proteins frac-
tionated by SDS-PAGE, Western blotted, and probed with anti-
MSL1 (top panel) or anti-MSL3 (bottom panel) antibody. Un-
incubated S2 cell lysate was included as a control (lane 1).
GST–JIL-1 (lane 3) as well as constructs containing each of the
kinase domains, GST-KDI (lane 5) and GST-KDII (lane 6), were
able to pull down the MSL complex as indicated by detection
with both MSL1 and MSL3 antibody, while no interaction was
observed with the GST-only control (lane 2) or the GST-NTD
(lane 4) or GST-CTD (lane 7) constructs.
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only one of the known MSL complex proteins to be lost
from the male X chromosomes upon treatment with
RNase (Richter et al., 1996). Moreover, the finding that
addition of GST–JIL-1 fusion protein to S2 cell extracts
can be used to pull down the MSL complex indicates that
this association can occur in vitro and suggests that the
JIL-1 kinase can interact with the preassembled MSL
complex. However, since this preassembled complex may
already contain endogenous JIL-1 it does not address
whether the formation of the MSL complex requires the
presence of JIL-1 protein or whether JIL-1 is present in
the MSL complex in stoichiometric amounts.
In contrast to the other MSL complex proteins, JIL-1 is
also present in female chromosomes and male autosomes
(Jin et al., 1999), all of which are void of MSL complexes
(Bashaw and Baker, 1996). Future experiments will deter-
mine whether JIL-1’s more general distribution on the au-
tosomes and on the female X chromosomes may reflect
JIL-1’s participation in other transcriptional regulator
complexes. The deployment of certain proteins into sev-
eral different chromatin remodeling complexes is emerg-
ing as a common theme in the composition of various
chromatin remodeling machines and may be a way to ac-
complish hierarchical levels of gene regulation (Holstege
et al., 1998). Here we have shown that JIL-1 associates
with at least one known chromatin remodeling machine,
the MSL complex, suggesting a direct link between the
JIL-1 kinase and the signal transduction pathways regulat-
ing transcription and chromatin structure.
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